Articles From: KiOR gets up to $25 million to stay in business to Kips Bay Medical Provides Business Update and Reports Second Quarter 2013 Results


2014/4/1
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of biofuels maker KiOR Inc. skyrocketed Tuesday on news the company is getting up to $25 million from billionaire backer Vinod Khosla to stay afloat.
Sign-up for KiOR gets up to $25 million to stay in business investment picks
Former Attorney General of Louisiana, Charles C.
Sign-up for KIOR INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates KiOR, Inc. Following Disclosure that Biofuel Shipments Missed Forecast investment picks
PASADENA, Texas, Sept.
Sign-up for KiOR Provides Operational Update on Columbus Facility investment picks
PASADENA, Texas, Dec.
Sign-up for KiOR Provides Operational Update on Columbus Facility investment picks
2013/8/8
Run Times and Reliability at Columbus Continue to Increase Facility Operating and Producing Oil First Cellulosic Gasoline Shipped PASADENA, Texas, Aug.
Sign-up for KiOR Reports Second Quarter 2013 Results investment picks
Columbus Transitioning to Steady State BFCC on Record Run Cornerstone Financial Commitments for Columbus II PASADENA, Texas, Nov.
Sign-up for KiOR Reports Third Quarter 2013 Results investment picks
2013/8/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1044972&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for KIOR SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against KiOR, Inc. - KIOR investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor, LLP announce that a federal class action lawsuit has been filed against KiOR, Inc. (“KiOR” or “Company”) (NasdaqGS: KIOR). The firms are investigating additional legal claims against the officers and Board of Directors of KiOR during the period of August 14, 2012 and August 7, 2013 (the “Class Period”). If you are an affected investor and you want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com , or Zachary Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at shareholder@powerstaylor.com .
Sign-up for KiOR Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
2014/2/20
PASADENA, Texas, Feb.
Sign-up for KiOR to Announce Fourth Quarter 2013 Financial Results on March 13, 2014 investment picks
2013/10/8
PASADENA, Texas, Oct.
Sign-up for KiOR to Announce Third Quarter 2013 Financial Results on November 7, 2013 investment picks
PASADENA, Texas, Sept.
Sign-up for KiOR to Present at Upcoming Credit Suisse Small & Mid Cap Investor Conference investment picks
2014/2/19
PASADENA, Texas, Feb.
Sign-up for KiOR to Present at Upcoming Raymond James Institutional Investors Conference investment picks
2013/8/27
http://media.marketwire.com/attachments/201107/5424_LeviAndKorsinsky_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1046213&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for KIOR, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against KiOR, Inc. and Its Board of Directors and Deadline of October 21, 2013 to Seek Lead Plaintiff Position investment picks
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased KiOR, Inc. (“Kior” or the “Company”) (NASDAQ:KIOR) securities between August 14, 2012 and August 7, 2013.
Sign-up for KIOR, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against KiOR, Inc. and Its Board of Directors and Deadline of October 21, 2013 to Seek Lead Plaintiff Position investment picks
2013/8/26
SAN DIEGO and PASADENA, Texas , Aug.
Sign-up for KiOR, Inc. Sued by Investor investment picks
Virtual Piggy, Inc. (OTCQB: VPIG) today announced that Oink was named ‘Best Savings Coach’ in Kiplinger’s 2013 Best of Everything guide.
Sign-up for Kiplinger Names Oink ‘Best Savings Coach’ investment picks
2013/11/14
KIPP DC, Volt Energy, Sol Systems, and Washington Gas Energy Systems are pleased to announce the grand opening of the new solar energy facility located at KIPP DC’s Douglass Campus in Washington, D.C. A private ribbon-cutting ceremony will take place on November 14, 2013 at 9:00 a.m. with Dot Harris from the Department of Energy serving as the keynote speaker.
Sign-up for KIPP DC, Volt Energy, Sol Systems, and Washington Gas Energy Systems Announce Ribbon-Cutting Ceremony for New Solar Energy System and Launch of STEM Awareness Program investment picks
2014/3/17
MINNEAPOLIS, March 17, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS) along with Manny Villafaña, its Founder, Chairman and CEO, announced today that the United States Food & Drug Administration ("FDA") has granted an approval for Kips Bay Medical to include more U.S. patients and U.S. study sites in its " eMESH I " clinical feasibility trial of its eSVS ® Mesh.
Sign-up for Kips Bay Medical Announces FDA Approval for U.S. Expansion of Its eMESH I Clincal Feasibility Study investment picks
2014/1/23
MINNEAPOLIS, Jan.
Sign-up for Kips Bay Medical Announces Pricing of Public Offering of 5,250,000 Shares of Common Stock investment picks
2014/1/23
MINNEAPOLIS, Jan.
Sign-up for Kips Bay Medical Announces Proposed Public Offering of Common Stock investment picks
2014/2/10
MINNEAPOLIS, Feb.
Sign-up for Kips Bay Medical Announces the First Austrian Implant of the eSVS Mesh investment picks
2013/9/18
Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS), announced that on September 4, 2013, the Emory Heart & Vascular Center in Atlanta, Georgia, performed its first implant of an eSVS ® Mesh.
Sign-up for Kips Bay Medical Announces the First eSVS® Mesh Implant by the Emory University Cardiothoracic Clinical Research Unit investment picks
2013/9/12
Kips Bay Medical, Inc. (NASDAQ: KIPS) , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery (CABG), announced that Manny Villafaña, its Chairman and Chief Executive Officer, has been invited to deliver a keynote address at the Aegis Capital Corp.
Sign-up for Kips Bay Medical Chairman and CEO Manny Villafaña to Present Keynote Address at the Aegis 2013 Health Care Conference investment picks
2013/9/4
Manny Villafaña, Chairman and Chief Executive Officer of Kips Bay Medical, Inc. (NASDAQ:KIPS) , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery (CABG), provided the following business update to Kips Bay shareholders and the financial community.
Sign-up for Kips Bay Medical Provides Business Update investment picks
2014/3/12
MINNEAPOLIS, March 12, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS) , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its fourth quarter and full year ended December 31, 2013.
Sign-up for Kips Bay Medical Provides Business Update and Reports Fourth Quarter and Full Year 2013 Results investment picks
Kips Bay Medical, Inc. (NASDAQ: KIPS) , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 29, 2013.
Sign-up for Kips Bay Medical Provides Business Update and Reports Second Quarter 2013 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: KiOR gets up to $25 million to stay in business to Kips Bay Medical Provides Business Update and Reports Second Quarter 2013 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity